Lonza Group Ag (OTCMKTS:LZAGY) Sees Significant Decrease in Short Interest

Lonza Group Ag (OTCMKTS:LZAGY) saw a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 27,933 shares, a decline of 64.1% from the August 31st total of 77,702 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 66,730 shares, the short-interest ratio is presently 0.4 days.

Lonza Group Stock Performance

Shares of OTCMKTS LZAGY traded up $0.11 during trading on Friday, reaching $69.13. The company had a trading volume of 73,342 shares, compared to its average volume of 45,839. The company’s fifty day moving average price is $69.43 and its 200-day moving average price is $65.96. The company has a current ratio of 2.24, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Lonza Group has a 12 month low of $58.53 and a 12 month high of $74.36.

Lonza Group Company Profile

Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology and healthcare industries. The company supports customers across the product life cycle, from early-stage development and clinical supply through commercial manufacturing and related regulatory services.

Lonza’s activities include the development and production of biologic medicines, small-molecule pharmaceuticals, active pharmaceutical ingredients, drug products, and specialized therapies.